UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 3/2012, Volume 67, Issue 3, pp. 715 - 722
Antifungal | Fungal infections | Combination therapy | Mould infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Mucormycosis - mortality | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Benzoates - administration & dosage | Drug Therapy, Combination - methods | Animals | Survival Analysis | Amphotericin B - administration & dosage | Adult | Female | Aged | Iron Chelating Agents - administration & dosage | Mice | Mucormycosis - drug therapy | Antifungal Agents - administration & dosage | Placebos - administration & dosage | Clinical trials | Drug therapy | Pathogenesis | Rodents | Mortality | Index Medicus | mould infections | antifungal | combination therapy | Original Research | fungal infections
Journal Article
Infection, ISSN 0300-8126, 12/2017, Volume 45, Issue 6, pp. 737 - 779
Extracorporeal membrane oxygenation | Critically ill | General Practice / Family Medicine | Internal Medicine | Liposomal amphotericin B | Medicine & Public Health | Amphotericin B lipid formulations | Polyenes | Voriconazole | Caspofungin | Echinocandins | Infectious Diseases | Renal replacement therapy | Itraconazole | Life Sciences & Biomedicine | Science & Technology | Tissue Distribution | Drug Interactions | Drug Therapy, Combination - utilization | Antifungal Agents - pharmacokinetics | Humans | Mycoses - drug therapy | Complications and side effects | Dosage and administration | Amphotericin B | Drug therapy | Cytochrome | Drugs | Brain | Therapy | Fungicides | Liver | Tissues | Heterocyclic compounds | Bioaccumulation | Spleen | Urine | Kidneys | Fluconazole | Isoenzymes | Cytochrome P450 | Cryptococcosis | Substrate inhibition | Pharmacology | Metabolism | Micafungin | Substrates | Mucormycosis | Azoles | Lungs | Aspergillosis | Myocardium | Flucytosine | Pharmacokinetics | Posaconazole | Kidney transplantation | Index Medicus | Review
Journal Article
The American journal of medicine, ISSN 0002-9343, 2012, Volume 125, Issue 1, pp. S25 - S38
Internal Medicine | Therapeutic drug monitoring | Echinocandins | Mucormycosis | Amphotericin B | Triazoles | Hepatotoxicity | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Mycoses - microbiology | Male | Alanine Transaminase - blood | Antineoplastic Agents - administration & dosage | Echinocandins - administration & dosage | Liver - drug effects | Antineoplastic Agents - adverse effects | Antifungal Agents - pharmacokinetics | Mycoses - metabolism | Adult | Female | Mucormycosis - surgery | Mucormycosis - drug therapy | Alkaline Phosphatase - blood | Myelodysplastic Syndromes - drug therapy | Aspergillosis - drug therapy | Flucytosine - administration & dosage | Liver - metabolism | Risk Factors | Leukemia - drug therapy | Mycoses - surgery | Pneumonia - microbiology | Biomarkers - blood | Bilirubin - blood | Flucytosine - adverse effects | Echinocandins - adverse effects | Pneumonia - drug therapy | Aspartate Aminotransferases - blood | Liver Function Tests - standards | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Immunocompromised Host | Drug Monitoring | Antifungal Agents - administration & dosage | Care and treatment | Mycoses | Diagnosis | Research | Health aspects | Risk factors | Drug therapy | Epidemiology | Fungal infections | Index Medicus | Abridged Index Medicus | Drugs | flucytosine | Pharmacodynamics | Risk groups | Mortality | Antifungal agents | Molds | triazoles | Radicals | Infection | Lipophilic | hepatotoxicity | Voriconazole | Pharmacokinetics | Posaconazole | Itraconazole
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 03/2017, Volume 72, Issue suppl_1, pp. i5 - i11
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Mucormycosis - epidemiology | Fusariosis - epidemiology | Humans | Scedosporium - drug effects | Drug Resistance, Fungal - physiology | Mucorales - drug effects | Fusarium - drug effects | Aspergillosis - epidemiology | Antifungal Agents - therapeutic use | Invasive Fungal Infections - drug therapy | Mucormycosis - microbiology | Aspergillosis - microbiology | Fusariosis - drug therapy | Immunocompromised Host | Mucormycosis - drug therapy | Invasive Fungal Infections - microbiology | Aspergillosis - drug therapy | Fusariosis - microbiology | Invasive Fungal Infections - immunology | Index Medicus
Journal Article